Clinical Trial Update: Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia [Phase 1]

View source ↗

Summary

A Phase 1 trial of Ferrous Sulphate Supplement (V0355) for iron deficiency anemia in women has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferrous Sulphate Supplement (V0355) (ferrous sulfate)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Iron Deficiency Anemia | Phase 1 | Status: TERMINATED